FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Recall of CPDA-1 Quadruple Blood-Pack Unit
Baxter Blood-Pack Unit (BPU) with Samplink Access Device

horizontal rule

DATE RECALL INITIATED:

    March 16, 2005

PRODUCT / SERIAL NUMBER / EXPIRATION DATE:

    Blood-Pack Unit with Samplink Access Device
    Product Code 4R1247MC

    Serial Number     Expiration Date

    M02I26046           3/31/2005
    M02I26046A         3/31/2005
    M02J10064           4/30/2005
    M02J10064A         4/30/2005
    M02K18032           5/31/2005
    M02K30029           5/31/2005
    M03A31067           7/31/2005
    M03B14038           8/31/2005
    M03B14038A         8/31/2005
    M03B28053           8/31/2005
    M03C21056           9/30/2005
    M03E28056           11/30/2005
    M03K06051           5/31/2006
    M04A17032           7/31/2006
    M04C26039           9/30/2006
    M04E07034           11/30/2006

MANUFACTURER:

    Baxter Healthcare Corporation
    Round Lake, Illinois

REASON:

    Baxter has determined that expired Samplink access devices were included in cases of Blood-Pack Unit, Product Code Number 4R1247MC (the Blood-Pack Units were not expired). Baxter will no longer supply the Samplink access device along with the Blood-Pack Units product in the same finished goods carton. The Blood-Pack Units product and the Samplink will be shipped in separate containers. Consignees have been asked to contact the manufacturer to arrange for product return.

horizontal rule

The information in this listing reflects CBER's best efforts to communicate information that has been reported to FDA. Its accuracy and comprehensiveness cannot be guaranteed.

 

 
horizontal rule